School of Clinical Medicine, North Sichuan Medical College, Nanchong, China.
Department of Vascular Surgery, Dazhou Central Hospital, Dazhou, China.
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231187392. doi: 10.1177/10760296231187392.
The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are emerging tools that can be used in the diagnosis of deep venous thrombosis (DVT). This study aims to evaluate the diagnostic value of NLR and PLR for patients with DVT. Our meta-analysis included 11 eligible studies and extracted relevant diagnostic indicators. Of these studies, 4 focused on the NLR, 1 on the PLR, while 6 evaluated both. For the 10 studies on NLR, the pooled sensitivity, specificity, positive-likelihood ratio, and negative-likelihood ratio were 74%, 66%, 2.16, and 0.4, respectively. The estimated diagnostic odds ratio (DOR) was 5.3, and the area under the curve (AUC) of the summary receiver operating characteristic (SROC) curves was 0.74. For the 7 studies on the PLR, the pooled sensitivity, specificity, positive-likelihood ratio, and negative-likelihood ratio were 0.65, 0.77, 2.89, and 0.45, respectively. The estimated DOR was 6.64, and the SROC-AUC was 0.79. Our findings showed that the NLR and PLR exhibit moderate diagnostic accuracy and may be helpful biomarkers for the diagnosis of DVT. Future prospective, well-designed studies with large sample sizes will be required to provide additional evidence to establish cutoff values and clinical value of these indicators.
中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)是新兴的工具,可用于诊断深静脉血栓形成(DVT)。本研究旨在评估 NLR 和 PLR 对 DVT 患者的诊断价值。我们的荟萃分析纳入了 11 项符合条件的研究,并提取了相关的诊断指标。其中 4 项研究关注 NLR,1 项研究关注 PLR,6 项研究同时评估了两者。对于 10 项 NLR 研究,汇总的敏感度、特异度、阳性似然比和阴性似然比分别为 74%、66%、2.16 和 0.4。估计的诊断比值比(DOR)为 5.3,汇总受试者工作特征(SROC)曲线下面积(AUC)为 0.74。对于 7 项 PLR 研究,汇总的敏感度、特异度、阳性似然比和阴性似然比分别为 0.65、0.77、2.89 和 0.45。估计的 DOR 为 6.64,SROC-AUC 为 0.79。我们的研究结果表明,NLR 和 PLR 具有中等的诊断准确性,可能是 DVT 诊断的有用生物标志物。未来需要进行前瞻性、设计良好、样本量大的研究,以提供更多证据来确定这些指标的截断值和临床价值。